Fecal matter for treatment of cachexia

Max Nieuwdorp; Willem Meindert De Vos

Fecal matter for treatment of cachexia

Max Nieuwdorp (Inventor), Willem Meindert De Vos (Inventor)

Research output: Patent

Abstract

The present invention relates to the use of allogenic fecal matter for the treatment of cachexia and/or cancer, wherein the allogenic fecal matter is obtained from at least one donor subject, wherein the at least one donor subject has a Body Mass Index (BMI) of at least 30 kg/m2, a HOMA-IR value below 2.5 mg/dL and/or an age below 60 years. Fecal matter from said at least one donor subject may be used to treat cancer and/or related conditions.

Original language	English
Patent number	WO2021254937
Priority date	19/06/20
Publication status	Published - 23 Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://nl.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2021254937A1&KC=A1&FT=D&ND=3&date=20211223&DB=&locale=nl_NL#

Cite this

@misc{ac55c4e4a6f7492390eb22a9c858fe9f,

title = "Fecal matter for treatment of cachexia",

abstract = "The present invention relates to the use of allogenic fecal matter for the treatment of cachexia and/or cancer, wherein the allogenic fecal matter is obtained from at least one donor subject, wherein the at least one donor subject has a Body Mass Index (BMI) of at least 30 kg/m2, a HOMA-IR value below 2.5 mg/dL and/or an age below 60 years. Fecal matter from said at least one donor subject may be used to treat cancer and/or related conditions.",

author = "Max Nieuwdorp and {De Vos}, {Willem Meindert}",

year = "2021",

month = dec,

day = "23",

language = "English",

type = "Patent",

note = "WO2021254937",

}

TY - PAT

T1 - Fecal matter for treatment of cachexia

AU - Nieuwdorp, Max

AU - De Vos, Willem Meindert

PY - 2021/12/23

Y1 - 2021/12/23

N2 - The present invention relates to the use of allogenic fecal matter for the treatment of cachexia and/or cancer, wherein the allogenic fecal matter is obtained from at least one donor subject, wherein the at least one donor subject has a Body Mass Index (BMI) of at least 30 kg/m2, a HOMA-IR value below 2.5 mg/dL and/or an age below 60 years. Fecal matter from said at least one donor subject may be used to treat cancer and/or related conditions.

AB - The present invention relates to the use of allogenic fecal matter for the treatment of cachexia and/or cancer, wherein the allogenic fecal matter is obtained from at least one donor subject, wherein the at least one donor subject has a Body Mass Index (BMI) of at least 30 kg/m2, a HOMA-IR value below 2.5 mg/dL and/or an age below 60 years. Fecal matter from said at least one donor subject may be used to treat cancer and/or related conditions.

M3 - Patent

M1 - WO2021254937

ER -

Fecal matter for treatment of cachexia

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this